J.P.
The FDA approved this morning a new indication for AstraZeneca’s (NYSE:AZN) ARP inhibitor Lynparza. The new indication is for use in patients with recurrent …
It is a good day to be a Puma Biotechnology Inc (NASDAQ:PBYI) investors, with shares soaring 38% and FDA sentiment looking favorably on …
On Friday, Acorda Therapeutics Inc (NASDAQ:ACOR) was met with misfortune after a district judge invalidated four patents for its multiple sclerosis drug Ampyra, …
Juno Therapeutics Inc (NASDAQ:JUNO) shares are dropping 7% following the biotech firm’s official termination of their JCAR015 program for the treatment of patients …
Gilead Sciences, Inc. (NASDAQ:GILD) announced yesterday positive phase 2 results for bictegravir vs.
Acorda Therapeutics Inc (NASDAQ:ACOR) shares rose 13% in Thursday’s trading session, after the drug maker announced topline data for CVT-301, an inhaled levodopa therapy …